Sunshine Biopharma Inc. Increase (Decrease) in Inventories
Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Inventories of -$872.39 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- Sunshine Biopharma Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$794.00K, a 243.04% decline year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$78.40K, a 113.78% decline year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$772.80K, a 142.82% decline year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.29M, a 2.66% increase year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in inventories for fiscal 2025 was $1.64M, a 72.74% decline from fiscal 2024.
- Sunshine Biopharma Inc. increase (decrease) in inventories for fiscal 2024 was $6.01M, a 153.93% increase from fiscal 2023.
- Sunshine Biopharma Inc. increase (decrease) in inventories for fiscal 2023 was $2.37M.
- Sunshine Biopharma Inc. increase (decrease) in inventories for fiscal 2022 was -$42.98K, a 152.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$794.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$872.39K 10-Q · filed 2026-08-13 | -$1.65M derived: sum of 3 quarters · filed 2026-08-13 | -$359.03K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$78.40K 10-Q · filed 2026-05-13 | -$851.20K derived: sum of 2 quarters · filed 2026-05-13 | $434.97K derived: sum of 3 quarters · filed 2026-05-13 | $990.04K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$772.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $513.37K derived: sum of 2 quarters · filed 2026-04-03 | $1.07M derived: sum of 3 quarters · filed 2026-08-13 | $1.64M 10-K · filed 2026-04-03 |
| 2025-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.84M derived: sum of 2 quarters · filed 2026-08-13 | $2.41M 10-Q · filed 2025-11-13 | $4.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $555.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.12M 10-Q · filed 2026-08-13 | $2.93M derived: sum of 3 quarters · filed 2026-08-13 | $4.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $568.83K 10-Q · filed 2026-05-13 | $2.37M derived: sum of 2 quarters · filed 2026-05-13 | $3.63M derived: sum of 3 quarters · filed 2026-05-13 | $4.48M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $3.06M derived: sum of 2 quarters · filed 2026-04-03 | $3.91M derived: sum of 3 quarters · filed 2026-04-03 | $6.01M 10-K · filed 2026-04-03 |
| 2024-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.10M derived: sum of 2 quarters · filed 2025-11-13 | $4.20M 10-Q · filed 2025-11-13 | $5.35M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $848.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.95M 10-Q · filed 2025-08-12 | $4.09M derived: sum of 3 quarters · filed 2025-08-12 | $4.43M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.10M 10-Q · filed 2025-05-15 | $3.24M derived: sum of 2 quarters · filed 2025-05-15 | $3.58M derived: sum of 3 quarters · filed 2025-05-15 | $4.05M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $1.48M derived: sum of 2 quarters · filed 2025-04-01 | $1.95M derived: sum of 3 quarters · filed 2025-04-01 | $2.37M 10-K · filed 2025-04-01 |
| 2023-09-30 | $335.87K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-05 | $803.79K derived: sum of 2 quarters · filed 2024-11-05 | $1.22M 10-Q · filed 2024-11-05 | $1.01M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $467.93K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-08-20 | $885.24K 10-Q/A · filed 2024-08-20 | $678.27K derived: sum of 3 quarters · filed 2024-08-20 | $742.54K derived: sum of 4 quarters · filed 2024-08-20 |
| 2023-03-31 | $417.32K 10-Q · filed 2024-05-20 | $210.34K derived: sum of 2 quarters · filed 2024-05-20 | $274.61K derived: sum of 3 quarters · filed 2024-05-20 | $300.47K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | -$206.97K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$142.70K derived: sum of 2 quarters · filed 2024-03-28 | -$116.85K derived: sum of 3 quarters · filed 2024-03-28 | -$42.98K 10-K · filed 2024-03-28 |
| 2022-09-30 | $64.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $90.13K derived: sum of 2 quarters · filed 2023-11-13 | $163.99K 10-Q · filed 2023-11-13 | $198.33K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $25.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $99.72K 10-Q · filed 2023-08-10 | $134.06K derived: sum of 3 quarters · filed 2023-08-10 | $153.86K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $73.86K 10-Q · filed 2023-05-10 | $108.20K derived: sum of 2 quarters · filed 2023-05-10 | $128.01K derived: sum of 3 quarters · filed 2023-05-10 | $152.85K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $34.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $54.14K derived: sum of 2 quarters · filed 2023-04-04 | $78.99K derived: sum of 3 quarters · filed 2023-04-04 | $81.88K 10-K · filed 2023-04-04 |
| 2021-09-30 | $19.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $44.65K derived: sum of 2 quarters · filed 2022-11-07 | $47.54K 10-Q · filed 2022-11-07 | $45.11K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $24.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $27.74K 10-Q · filed 2022-08-03 | $25.31K derived: sum of 3 quarters · filed 2022-08-03 | $34.93K derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $2.89K 10-Q · filed 2022-05-06 | $459.00 derived: sum of 2 quarters · filed 2022-05-06 | $10.08K derived: sum of 3 quarters · filed 2022-05-06 | $12.95K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$2.43K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $7.20K derived: sum of 2 quarters · filed 2022-03-21 | $10.06K derived: sum of 3 quarters · filed 2022-03-21 | $7.86K 10-K · filed 2022-03-21 |
| 2020-09-30 | $9.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $12.49K derived: sum of 2 quarters · filed 2021-11-09 | $10.29K 10-Q · filed 2021-11-09 | $8.42K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $666.00 10-Q · filed 2021-08-09 | -$1.20K derived: sum of 3 quarters · filed 2021-08-09 | -$1.62K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$2.20K 10-Q · filed 2021-05-11 | -$4.07K derived: sum of 2 quarters · filed 2021-05-11 | -$4.48K derived: sum of 3 quarters · filed 2021-05-11 | $475.00 derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$1.87K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$2.28K derived: sum of 2 quarters · filed 2021-03-30 | $2.67K derived: sum of 3 quarters · filed 2021-03-30 | $15.91K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$415.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-12 | $4.54K derived: sum of 2 quarters · filed 2020-11-12 | $17.78K 10-Q · filed 2020-11-12 | -$5.61K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $4.96K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $18.19K 10-Q/A · filed 2020-08-31 | -$5.19K derived: sum of 3 quarters · filed 2020-08-31 | $18.19K derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $13.24K 10-Q · filed 2020-05-18 | -$10.15K derived: sum of 2 quarters · filed 2020-05-18 | $13.24K derived: sum of 3 quarters · filed 2020-05-18 | $13.24K derived: sum of 4 quarters · filed 2020-05-18 |
| 2018-12-31 | -$23.38K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $0.00 derived: sum of 2 quarters · filed 2020-05-01 | $0.00 derived: sum of 3 quarters · filed 2020-05-01 | $0.00 10-K · filed 2020-05-01 |
| 2018-09-30 | $23.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $23.38K derived: sum of 2 quarters · filed 2019-11-13 | $23.38K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $0.00 10-Q · filed 2019-08-15 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |